These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 37163782)

  • 1. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis.
    Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
    Biomed Pharmacother; 2023 Jul; 163():114806. PubMed ID: 37163782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis: new targets for the development of anticancer chemotherapies.
    Gourley M; Williamson JS
    Curr Pharm Des; 2000 Mar; 6(4):417-39. PubMed ID: 10788590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic therapy for cancer: an update.
    Al-Husein B; Abdalla M; Trepte M; Deremer DL; Somanath PR
    Pharmacotherapy; 2012 Dec; 32(12):1095-111. PubMed ID: 23208836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of angiogenesis in cancers.
    Pang RW; Poon RT
    Vasc Health Risk Manag; 2006; 2(2):97-108. PubMed ID: 17319453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor angiogenesis and therapy.
    Cao Y
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S340-3. PubMed ID: 16507405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
    Wilson PM; LaBonte MJ; Lenz HJ
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic strategies and agents in clinical trials.
    Rosen L
    Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.
    Shanmugam MK; Warrier S; Kumar AP; Sethi G; Arfuso F
    Curr Vasc Pharmacol; 2017; 15(6):503-519. PubMed ID: 28707601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic alternatives to VEGF blockade.
    Khan KA; Bicknell R
    Clin Exp Metastasis; 2016 Feb; 33(2):197-210. PubMed ID: 26620208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Angiogenics: Current Situation and Future Perspectives.
    Zirlik K; Duyster J
    Oncol Res Treat; 2018; 41(4):166-171. PubMed ID: 29562226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of selected patents for cancer therapy targeting tumor angiogenesis.
    Kirstein MN; Moore MM; Dudek AZ
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):153-61. PubMed ID: 18221033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in cancer: molecular mechanisms, clinical impact.
    Eichhorn ME; Kleespies A; Angele MK; Jauch KW; Bruns CJ
    Langenbecks Arch Surg; 2007 May; 392(3):371-9. PubMed ID: 17458577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and Challenges in Tumor Anti-Angiogenic Therapies.
    Jászai J; Schmidt MHH
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility.
    Close A
    Future Med Chem; 2016; 8(4):443-62. PubMed ID: 26933926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.
    Ranieri G; Gasparini G
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):241-53. PubMed ID: 12477290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic therapy for the treatment of pediatric solid malignancies.
    Davidoff AM; Kandel JJ
    Semin Pediatr Surg; 2004 Feb; 13(1):53-60. PubMed ID: 14765371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to antiangiogenic therapies.
    Bartolotti M; Franceschi E; Poggi R; Tosoni A; Di Battista M; Brandes AA
    Future Oncol; 2014 Jun; 10(8):1417-25. PubMed ID: 25052752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis inhibitors in cancer therapy.
    Dredge K; Dalgleish AG; Marriott JB
    Curr Opin Investig Drugs; 2003 Jun; 4(6):667-74. PubMed ID: 12901224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.